NasdaqCM - Nasdaq Real Time Price USD

Firefly Neuroscience, Inc. (AIFF)

Compare

2.2700

-0.1300

(-5.42%)

At close: 4:00:01 PM EST

2.1600

-0.11

(-4.85%)

After hours: 6:04:48 PM EST

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Name	Title	Pay	Exercised	Year Born
Mr. Jon Olsen	CEO & Director	168.38k	--	1965
Mr. Gil Issachar	Chief Technology Officer	192.87k	--	1982
Mr. David Ian Johnson	Executive Chairman	--	--	1958
Dr. Jason DuBraski	Vice President of Sales	--	--	--
Dr. Samer E. Kaba M.D.	Chief Medical Officer	--	--	1962

150 King St W

Suite 722

Toronto, ON M5H 1J9

Canada

888-237-6412 https://fireflyneuro.com

Sector:: Technology
Industry:

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Firefly Neuroscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events Information Not Available

January 8, 2025 at 12:00 AM UTC

PRE 14A: Proxy Statements

See Full Filing

January 6, 2025 at 12:00 AM UTC